Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti–Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease

Uloženo v:

Podrobná bibliografie
Hlavní autoři:	Mario Cottone, Anna Kohn, Marco Daperno, Alessandro Armuzzi, Luisa Guidi, R. D’Incà, Fabrizio Bossa, Erika Angelucci, Livia Biancone, Paolo Gionchetti, Sandro Ardizzone, Claudio Papi, Walter Fries, Silvio Danese, Gabriele Riegler, Maria Cappello, Fabiana Castiglione, Vito Annese, Ambrogio Orlando
Médium:	Artigo
Jazyk:	angličtina
Vydáno:	2010
On-line přístup:	https://doi.org/10.1016/j.cgh.2010.09.026
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease
Autor: Paolo Gionchetti, a další
Vydáno: (2017)

Adalimumab in active ulcerative colitis: A “real-life” observational study
Autor: Alessandro Armuzzi, a další
Vydáno: (2013)

Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort
Autor: Ambrogio Orlando, a další
Vydáno: (2014)

Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy
Autor: Rita Monterubbianesi, a další
Vydáno: (2014)

Unmet Medical Needs in the Management of Ulcerative Colitis: Results of an Italian Delphi Consensus
Autor: Daperno, Marco, a další
Vydáno: (2019)

Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Autor: Livia Biancone, a další
Vydáno: (2017)

Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up
Autor: Anna Kohn, a další
Vydáno: (2007)

Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists
Autor: Marco Daperno, a další
Vydáno: (2016)

Incident Colorectal Cancer in Inflammatory Bowel Disease
Autor: Neri, Benedetto, a další
Vydáno: (2022)

Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?
Autor: Vecchi, Maurizio, a další
Vydáno: (2013)

Replication of interleukin 23 receptor and autophagyrelated 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy
Autor: Anna Latiano, a další
Vydáno: (2008)

Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy
Autor: Latiano, Anna, a další
Vydáno: (2008)

Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case–Control IG-IBD Study
Autor: Livia Biancone, a další
Vydáno: (2019)

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study
Autor: Biancone, L, a další
Vydáno: (2006)

Polymorphisms of Tumor Necrosis Factor‐α but Not <i>MDR1</i> Influence Response to Medical Therapy in Pediatric‐Onset Inflammatory Bowel Disease
Autor: Salvatore Cucchiara, a další
Vydáno: (2007)

Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology
Autor: Fabio Salvatore Macaluso, a další
Vydáno: (2023)

Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology
Autor: Fabio Salvatore Macaluso, a další
Vydáno: (2022)

Two mesalazine regimens in the prevention of the post‐operative recurrence of Crohn's disease: a pragmatic, double‐blind, randomized controlled trial
Autor: R. Caprilli, a další
Vydáno: (2003)

Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients
Autor: Latiano, Anna, a další
Vydáno: (2011)

Investigation of Multiple Susceptibility Loci for Inflammatory Bowel Disease in an Italian Cohort of Patients
Autor: Anna Latiano, a další
Vydáno: (2011)

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy
Autor: Alessandro Armuzzi, a další
Vydáno: (2018)

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women
Autor: N Pedersen, a další
Vydáno: (2013)

Mongersen, an Oral <i>SMAD7</i> Antisense Oligonucleotide, and Crohn’s Disease
Autor: Giovanni Monteleone, a další
Vydáno: (2015)

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors
Autor: Claudio Papi, a další
Vydáno: (2013)

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease
Autor: R. D’Incà, a další
Vydáno: (2006)

Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study
Autor: Bezzio, Cristina, a další
Vydáno: (2021)

Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Autor: Latiano, Anna, a další
Vydáno: (2013)

Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Autor: Anna Latiano, a další
Vydáno: (2013)

Polymorphism of the IRGM Gene Might Predispose to Fistulizing Behavior in Crohn's Disease
Autor: Anna Latiano, a další
Vydáno: (2008)

Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Autor: Gionata Fiorino, a další
Vydáno: (2019)

Measuring disease activity in Crohn’s disease: what is currently available to the clinician
Autor: D’Incà, Renata, a další
Vydáno: (2014)

Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Autor: Andrea Michielan, a další
Vydáno: (2015)

Measuring disease activity in Crohn&#39;s disease: what is currently available to the clinician
Autor: R. D’Incà, a další
Vydáno: (2014)

Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission
Autor: Francesca Palone, a další
Vydáno: (2016)

Enteropathic spondyloarthropathy: A common genetic background with inflammatory bowel disease?
Autor: Colombo, Elisabetta, a další
Vydáno: (2009)

New biologics in the management of Crohn’s disease: focus on certolizumab pegol
Autor: Colombo, Elisabetta, a další
Vydáno: (2009)

Hepatitis B and C Virus Infection in Crohn's Disease
Autor: Livia Biancone, a další
Vydáno: (2001)

Risk factors for non‐adherence to medication in inflammatory bowel disease patients
Autor: R. D’Incà, a další
Vydáno: (2007)

Exosomes: Tiny Clues for Mast Cell Communication
Autor: D’Incà, Federica, a další
Vydáno: (2015)

Synthesis of citrovorum factor in rats given chloretone
Autor: Mitbander, V. B., a další
Vydáno: (1955)